Discordant QuantiFERON-TB gold test results among US healthcare workers with increased risk of latent tuberculosis infection: A problem or solution?

Infection Control and Hospital Epidemiology

Volumn 29, Issue 9, 2008, Pages 878-886

  Pollock, Nira R ^a,c   Campos Neto, Antonio ^a   Kashino, Suely ^a   Napolitano, Danielle ^a   Behar, Samuel M ^a   Shin, Daniel ^a   Sloutsky, Alex ^b   Joshi, Swati ^b   Guillet, Jasmine ^b   Wong, Michael ^a   Nardell, Edward ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Massachusetts State Laboratory   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; TUBERCULIN;

ALGORITHM; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSPOT ASSAY; HEALTH CARE PERSONNEL; HUMAN; IMMUNOASSAY; INFECTION RISK; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; QUALITY CONTROL; QUANTIFERON TB GOLD ASSAY; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; SENSITIZATION; T LYMPHOCYTE ACTIVATION; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

ADULT; ALGORITHMS; FEMALE; HEALTH PERSONNEL; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; QUALITY ASSURANCE, HEALTH CARE; REAGENT KITS, DIAGNOSTIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 51849122119     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/590262     Document Type: Article

References (40)

1. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States [erratum appears in MMWR Morb Wkly Rep 2005; 54:1288].
2. MMWR Recomm Rep 2005; 54(RR-15):49-55.
3. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-1204.
4. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians; 2006.
5. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161(4 Pt 2):S221-247.
6. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1-141.
7. Public Health Agency of Canada. International Tuberculosis Incidence Rates. Available at: http://www.phac-aspc.gc.ca/tbpc-latb/itir-eng.php. Accessed December 12, 2007.
8. QuantiFERON-TB Gold assay notes [package insert]. Victoria, Australia: Victorian Infectious Diseases Reference Laboratory; 2006.
9. T-SPOT.TB [package insert]. Oxfordshire, UK: Oxford Immunotec; 2006.
10. T-SPOT.TB Visual Procedure Guide. Oxfordshire, UK: Oxford Immunotec; 2005.
11. QuantiFERON-TB Gold In Tube [package insert]. Victoria, Australia: Cellestis; 2006.
12. Mukherjee S, Kashino SS, Zhang Y, et al. Cloning of the gene encoding a protective Mycobacterium tuberculosis secreted protein detected in vivo during the initial phases of the infectious process. J Immunol 2005;175:5298-5305.
13. Seibert FB, Glenn J. Tuberculin purified protein derivative: preparation and analysis of a large quantity for standard.AmRev Tuberc 1941;44:9-25.
14. Mazurek GH, Zajdowicz MJ, Hankinson AL, et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis 2007;45:826-836.
15. Tuberculosis among foreign-born persons who had recently arrived in the United States-Hawaii, 1992-1993, and Los Angeles County. MMWR. 1993;44:703-707.
16. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl tuberculosea 1970;26:28-106.
17. Sutherland I. The ten-year incidence of clinical tuberculosis following "conversion" in 2550 individuals aged 14 to 19 years. Tuberculosis Surveillance and Research Unit Progress Report. The Hague: Royal Netherlands Tuberculosis Association (KNCV); 1968.
18. Trends in tuberculosis - United States, 2005. MMWR Morb Mortal Wkly Rep 2006;55:305-308.
19. Porsa E, Cheng L, Graviss EA. Comparison of an ESAT-6/CFP-10 peptide-based enzyme-linked immunospot assay to a tuberculin skin test for screening of a population at moderate risk of contracting tuberculosis. Clin Vaccine Immunol 2007;14:714-719.
20. Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007;175:618-627.
21. Richeldi L, Ewer K, Losi M, et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med 2004;170:288-295.
22. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004;170:65-69.
23. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-1173.
24. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-354.
25. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006;174:736-742.
26. Cehovin A, Cliff JM, Hill PC, Brookes RH, Dockrell HM. Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection. Clin Vaccine Immunol 2007;14:796-798.
27. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 2007;14:880-885.
28. Reece ST, Stride N, Ovendale P, Reed SG, Campos-Neto A. Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigs. Infect Immun 2005;73:3301-3306.
29. Kamath AB, Woodworth J, Xiong X, Taylor C, Weng Y, Behar SM. Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J Exp Med 2004;200:1479-1489.
30. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006;27:442-448.
31. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005;293:2746-2755.
32. Drobniewski F, Balabanova Y, Zakamova E, Nikolayevskyy V, Fedorin I. Rates of latent tuberculosis in health care staff in Russia. PLoS Med 2007;4:e55.
33. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:2060-2067.
34. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-138.
35. Jeyakumar D. Tuberculin reactivity and subsequent development of tuberculosis in a cohort of student nurses. Med J Malaysia 1999;54:492-495.
36. Leung CC, Yew WW, Chang KC, et al. Risk of active tuberculosis among schoolchildren in Hong Kong. Arch Pediatr Adolesc Med 2006;160:247-251.
37. Comstock GW, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis 1979;119:827-830.
38. Richeldi L, Ewer K, Losi M, et al. T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics 2007;119:e1-5.
39. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002;40:704-706.
40. Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 2007;13:175-182.